TITLE

Are the Pleiotropic Effects of Telmisartan Clinically Relevant?

AUTHOR(S)
Rizos, C. V.; Elisaf, M. S.; Liberopoulos, E. N.
PUB. DATE
August 2009
SOURCE
Current Pharmaceutical Design;8/21/2009, Vol. 15 Issue 24, p2815
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Hypertension is one of the major risk factors for cardiovascular disease. Angiotensin receptor blockers (ARBs) are a class of antihypertensive drugs with established efficacy and favorable safety profile. Telmisartan, a member of the ARB family, holds some additional traits which differentiate it from the rest ARBs. A pivotal role in these characteristics plays its ability to partially activate the peroxisome proliferator activated receptor-?, which in turn controls a number of metabolism-related genes. Indeed, telmisartan has shown a number of pleiotropic effects in experimental and clinical studies. These include the amelioration of insulin resistance, improvement of lipid profile and favorable fat redistribution. Moreover, telmisartan has been associated with beneficial effects on vascular function, cardiac remodeling and renal function. However, do all these pleiotropic effects translate into clinical benefit? Recent studies have tried to answer this question with promising but not definitive results.
ACCESSION #
43974781

 

Related Articles

  • Combination therapy for hypertension. Elliott, William T. // Infectious Disease Alert;Feb2009 Pharmacology Watch, p1 

    The article discusses research being done on the effectiveness of benazepril plus amlodipine or hydrochlorothiazide for hypertension in high risk patients. It references a study by K. Jamerson and colleagues published in a 2008 issue of the "New England Journal of Medicine." For the study,...

  • A Prospective Evaluation of Antihypertensive Medications Safety and Efficacy in United Arab Emirates Private Hospitals. Alomar, Muaed Jamal; Strauch, Claire Caroline // American Journal of Pharmacology & Toxicology;2010, Vol. 5 Issue 2, p89 

    Problem statement: Hypertension is one of the most important risk factors for heart and cardiovascular diseases in the United Arab Emirates (UAE). Evaluation of the safety and efficacy of antihypertensive medications in UAE private hospitals is important. The importance arises because of the...

  • Meta-analysis Compares Antihypertensive Classes. Elliott, William T. // Clinical Cardiology Alert;Aug2009 Pharmacology Watch, p1 

    The article discusses research on antihypertensive drugs. It references a study published in the 2009 issue of "British Medical Journal." Study authors analyzed the efficacy of thiazides, beta-blockers, angiotensin-converting enzyme inhibitors, angiotensin-receptor blockers and calcium-channel...

  • Angiotensin II Blockade and Total Cardiovascular Risk. Cipollone, Francesco; Di Fabio, Sara; Bucci, Marco; Cicolini, Giancarlo; Mezzetti, Andrea // High Blood Pressure & Cardiovascular Prevention;Nov2008, Vol. 15 Issue 4, p245 

    Hypertension is one of the world's largest public health problems and it is both a disease and a risk factor for cardiovascular disease (CVD). The heart, the endothelium and the kidneys are the target organs of hypertension. Recently, several antihypertensive drugs have been introduced to the...

  • Drugs yield "surprising" BP control.  // Cortlandt Forum;7/25/2005, Vol. 18 Issue 7, p18 

    Reports that a combination of irbesartan and hydrochlorothiazide can reduce systolic blood pressure (SBP) in patients with mild-to-moderate hypertension. Percentage on the reduction in SBP after eighteen weeks of combined therapy; Dosage of the combined therapy administered to the patients;...

  • Isolation, Structural Determination, and Evaluation of the Biological Activity of 20(S)-25-methoxyl-dammarane-3β, 12β, 20-triol [20(S)-25-OCH3-PPD], a Novel Natural Product from Panax notoginseng. Zhao, Y.; Wang, W.; Han, L.; Rayburn, E. R.; Hill, D. L.; Wang, H.; Zhang, R. // Medicinal Chemistry;2007, Vol. 3 Issue 1, p51 

    No abstract available.

  • Tips from Other Journals. MOON, KENNETH T. // American Family Physician;10/15/2009, Vol. 80 Issue 8, p882 

    The article discusses research on the findings of the "Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial" (ALLHAT) in 2000. It references the study "ALLHAT Findings Revisited in the Context of Subsequent Analyses, Other Trials, and Meta-analyses," by J. T. Wright Jr....

  • Review: First-line low-dose thiazides and ACE inhibitors reduce mortality and morbidity in adults with hypertension. Shah, Nirav R.; Ogedegbe, Gbenga // ACP Journal Club;1/19/2010, Vol. 152 Issue 1, p3 

    The article discusses a study conducted by researcher J.M. Wright and colleagues to know benefits of major first-line antihypertensive drug classes. The study has found that in adults with hypertension, low-dose thiazides have the most evidence for cardiovascular benefit followed by...

  • Secondary stroke prophylaxis: ARB bests calcium antagonist.  // Formulary;May2005, Vol. 40 Issue 5, p157 

    Discusses a study which suggested that the angiotensin receptor blocker (ARB) eprosartan is superior to the calcium antagonist nitrendipine in secondary stroke prophylaxis in patients with hypertension. Findings reported by Dr. Hans-Chrisdan Diener at the American Stroke Association's...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics